Literature DB >> 9302008

Disruption of IcsP, the major Shigella protease that cleaves IcsA, accelerates actin-based motility.

K D Shere1, S Sallustio, A Manessis, T G D'Aversa, M B Goldberg.   

Abstract

Shigella pathogenesis involves bacterial invasion of colonic epithelial cells and movement of bacteria through the cytoplasm and into adjacent cells by means of actin-based motility. The Shigella protein IcsA (VirG) is unipolar on the bacterial surface and is both necessary and sufficient for actin-based motility. IcsA is inserted into the outer membrane as a 120-kDa polypeptide that is subsequently slowly cleaved, thereby releasing the 95-kDa amino-terminal portion into the culture supernatant. IcsP, the major Shigella protease that cleaves IcsA, was identified and cloned. It has significant sequence similarity to the E. coli serine proteases, OmpP and OmpT. Disruption of icsP in serotype 2a S. flexneri leads to a marked reduction in IcsA cleavage, increased amounts of IcsA associated with the bacterium and altered distribution of IcsA on the bacterial surface. The icsP mutant displays significantly increased rates of actin-based motility, with a mean speed 27% faster than the wild-type strain; moreover, a significantly greater percentage of the icsP mutant moves in the cytoplasm. Yet, plaque formation on epithelial monolayers by the mutant was not altered detectably. These data suggest that IcsA, and not a host protein, is limiting in the rate of actin-based motility of wild-type serotype 2a S. flexneri.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9302008     DOI: 10.1046/j.1365-2958.1997.4681827.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  56 in total

1.  The sigA gene which is borne on the she pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation.

Authors:  K Al-Hasani; I R Henderson; H Sakellaris; K Rajakumar; T Grant; J P Nataro; R Robins-Browne; B Adler
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Periplasmic transit and disulfide bond formation of the autotransported Shigella protein IcsA.

Authors:  L D Brandon; M B Goldberg
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

Review 3.  Actin-based motility of intracellular microbial pathogens.

Authors:  M B Goldberg
Journal:  Microbiol Mol Biol Rev       Date:  2001-12       Impact factor: 11.056

Review 4.  Molecular basis of the intracellular spreading of Shigella.

Authors:  T Suzuki; C Sasakawa
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  Polar targeting of Shigella virulence factor IcsA in Enterobacteriacae and Vibrio.

Authors:  M Charles; M Pérez; J H Kobil; M B Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

6.  Crystal structure of the outer membrane protease OmpT from Escherichia coli suggests a novel catalytic site.

Authors:  L Vandeputte-Rutten; R A Kramer; J Kroon; N Dekker; M R Egmond; P Gros
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

Review 7.  Polarity in action: asymmetric protein localization in bacteria.

Authors:  S R Lybarger; J R Maddock
Journal:  J Bacteriol       Date:  2001-06       Impact factor: 3.490

8.  Evidence for polar positional information independent of cell division and nucleoid occlusion.

Authors:  Anuradha Janakiraman; Marcia B Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-08       Impact factor: 11.205

9.  Regulation of IcsP, the outer membrane protease of the Shigella actin tail assembly protein IcsA, by virulence plasmid regulators VirF and VirB.

Authors:  Helen J Wing; Arthur W Yan; Seth R Goldman; Marcia B Goldberg
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

Review 10.  From self sufficiency to dependence: mechanisms and factors important for autotransporter biogenesis.

Authors:  Denisse L Leyton; Amanda E Rossiter; Ian R Henderson
Journal:  Nat Rev Microbiol       Date:  2012-02-16       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.